Immunovant, Inc.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fra…
Biotechnology
US, New York [HQ]
Growth Rates · Payout · Yield
Dividends Over Time
Growth Rates · Payout · YieldSearching for a Dividend Aristocrat? Sign Up to view the entire dividend history of Immunovant, Inc.
Growth Rates
0.00%
YoY
0.00%
3Yr
0.00%
5Yr
0.00%
10Yr
Key Metrics
- -%
TTM Yield
- -
Average Days Gap
Series
- -%
Yield
0.00%
Payout Ratio
History
We could not find any dividend history for Immunovant, Inc..